Navigation Links
Third Circuit Rules in Mylan's Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylan's Breach of Contract Claim Against GSK to Trial
Date:7/23/2013

PITTSBURGH, July 23, 2013 /PRNewswire/ -- Mylan Inc. (NASDAQ: MYL) today announced that the Third Circuit Court of Appeals has reversed a summary judgment ruling dismissing Mylan's claim for breach of contract against GlaxoSmithKline relating to Paroxetine Hydrochloride Extended-release (ER) Tablets. The court ordered that Mylan's contract claim proceed to trial in U.S. District Court for the District of New Jersey. Mylan had filed suit against GSK claiming that GSK's agreement to supply Apotex with Paroxetine Hydrochloride ER violated Mylan's settlement and license agreement with GSK.  Mylan is seeking money damages and an order permanently enjoining GSK from supplying Apotex with Paroxetine Hydrochloride ER. The company is pleased with the court's decision and the case will proceed to trial.

This press release includes statements that constitute "forward-looking statements," including with regard to litigation and sales of the product. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: strategies by competitors or other third parties to delay or prevent product introductions; risks inherent in legal and regulatory processes; and the other risks detailed in the company's periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the wor
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rochester Medical Announces Third Quarter 2013 Earnings Conference Call Tuesday, July 30, 2013
2. Hill-Rom Announces Preliminary Fiscal 2013 Third Quarter Results and Search for New CFO; Adjusted Earnings Per Share Expected to be in Line with Guidance
3. Span-America Medical Systems to Release Third Quarter Results on July 31, 2013
4. Aviir Secures Third $10 Million Financing Tranche To Fund Expanded Sales Of New Heart Risk Test
5. New Research: Nationwide Report Shows Prescribed Drugs Not Detected in More Than One-Third of Pain Patient Samples
6. Lilly Declares Third-Quarter 2013 Dividend
7. Cantel Medical Reports EPS of $0.33 vs. $0.30 on 8% Sales Increase for Third Quarter Ended April 30, 2013
8. Cantel Medical Corp. To Hold Conference Call To Discuss Results for Its Third Quarter Ended April 30, 2013
9. Hill-Rom Increases Third Quarter 2013 Dividend
10. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
11. TPI Reports Third Quarter Fiscal Year 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Research and Markets has announced the addition ... report to their offering. Benefiting ... for medical expenses, the Chinese orthopedic instrument market demand ... CAGR of 19.2% during 2009-2013. Trauma products, spine products ... instruments in China , of which ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
(Date:8/29/2014)... August 29, 2014 According ... Product & Services (Equipment, Reagent, Primer, Probe, Custom ... PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - ... global Oligonucleotide Synthesis Market is expected to reach ... 2014, growing at a CAGR of 9.8% from ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... (Allscripts – NASDAQ: MDRX ) today announced its ... (Logo:   http://photos.prnewswire.com/prnh/20100901/CG58147LOGO ) Third ... million, compared to $198.6 million in the third quarter of ... of $368.8 million; non-GAAP revenue of $371.4 million, a 13 ...
...  Prescription copay coupon marketing programs, which lure insured consumers ... increase costs by $32 billion over the next decade, ... by the Pharmaceutical Care Management Association (PCMA). ... undermine efforts by employers, unions and state governments to ...
Cached Medicine Technology:Allscripts Reports Third Quarter 2011 Results 2Allscripts Reports Third Quarter 2011 Results 3Allscripts Reports Third Quarter 2011 Results 4Allscripts Reports Third Quarter 2011 Results 5Allscripts Reports Third Quarter 2011 Results 6Allscripts Reports Third Quarter 2011 Results 7Allscripts Reports Third Quarter 2011 Results 8Allscripts Reports Third Quarter 2011 Results 9Allscripts Reports Third Quarter 2011 Results 10Allscripts Reports Third Quarter 2011 Results 11Allscripts Reports Third Quarter 2011 Results 12Allscripts Reports Third Quarter 2011 Results 13Allscripts Reports Third Quarter 2011 Results 14Allscripts Reports Third Quarter 2011 Results 15Allscripts Reports Third Quarter 2011 Results 16Report: Brand Drug 'Copay Coupons' Raise Health Costs for Employers, Unions, and State Governments by $32 Billion 2
(Date:8/30/2014)... August 30, 2014 The federal ... lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed against Boston Scientific ... four cases selected for one of the proceeding’s ... August 18, 2014, U.S. District Judge Joseph R. ... disagrees with Boston Scientific’s contention that a consolidated ...
(Date:8/30/2014)... August 2014: Transvenous lead extraction (TLE) is clinically successful ... from the European Lead Extraction ConTRolled (ELECTRa) registry presented ... by Dr Maria Grazia Bongiorni, chair of the registry,s ... cardiac implantable electronic devices (CIED) implant procedures has grown ... of complications has increased and leads are often the ...
(Date:8/30/2014)... 2014 In today’s world, a good ... to get. Snoring and sleep apnea (a medical problem ... robs people and their bed partners of the rest ... 45% of the population snores and 20 million people ... these, only 10% have been diagnosed and treated; and ...
(Date:8/30/2014)... Top10BestSEOHosting.com is a well-known review website. Recently, ... http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts is the best Windows Hosting ... announced that Bluehost and Arvixe are excellent companies ... the Top 10 Web Hosting in 2014, is ... it offers rich features and great Windows hosting ...
(Date:8/30/2014)... August 30, 2014 Removecomplaints.net, a well-known ... industry, has announced to offer guarantee of results with ... offer this guarantee because of its tremendous track record. ... clients from all over the world and received recommendation ... job. , On being asked about the announcement, ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2Health News:Removecomplaints.net Announces Guaranteed Complaints Removal Services 2
... the Company,s line of health and beauty strategic ... AdEx Media, Inc. (OTC Bulletin Board: ADXM), ... platform services company, today announced the addition of ... product strategic partnerships. RezActiv(TM) was formulated by ...
... to outlook of $65.0 to $69.0 million- Case shipments of ... - GAAP diluted EPS of $0.04, compared to outlook of ... (Nasdaq: ALGN ) today reported financial results for ... Total net revenues for the first quarter of fiscal 2009 ...
... exposure and its associated risks, according to a study ... , "More than 100 surveys were completed by physicians ... tertiary-care teaching hospital," said Jeremy McBride, MD, lead author ... assessed, 63% underestimated the radiation dose of one abdominal-pelvic ...
... 23 Last night, Oklahoma Governor Brad Henry vetoed ... for any Oklahoma business to conduct research that would ... to a substantial risk of death or injury. ... however, the Oklahoma Senate failed to follow suit.The bill ...
... one of the market,s leading Security as a Service ... Trust Award for "Best Managed Security Service" for the ... at the exclusive, SC Magazine Awards Gala, held in ... Managed Security Services competed against those from MessageLabs (now ...
... VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) ... for its lead oncology therapeutic Onrigin(TM) (laromustine) Injection has ... and Drug Administration (FDA). Therefore, a user fee goal ... the FDA with respect to the approval of the ...
Cached Medicine News:Health News:AdEx Media Introduces RezActiv(TM) 2Health News:AdEx Media Introduces RezActiv(TM) 3Health News:Align Technology Announces First Quarter Fiscal 2009 Results 2Health News:Align Technology Announces First Quarter Fiscal 2009 Results 3Health News:Align Technology Announces First Quarter Fiscal 2009 Results 4Health News:Align Technology Announces First Quarter Fiscal 2009 Results 5Health News:Align Technology Announces First Quarter Fiscal 2009 Results 6Health News:Align Technology Announces First Quarter Fiscal 2009 Results 7Health News:Align Technology Announces First Quarter Fiscal 2009 Results 8Health News:Align Technology Announces First Quarter Fiscal 2009 Results 9Health News:Align Technology Announces First Quarter Fiscal 2009 Results 10Health News:Align Technology Announces First Quarter Fiscal 2009 Results 11Health News:Align Technology Announces First Quarter Fiscal 2009 Results 12Health News:Align Technology Announces First Quarter Fiscal 2009 Results 13Health News:Majority of ordering physicians lack knowledge of radiation exposure risks from CT 2Health News:SecureWorks, Inc. Wins SC Magazine's Reader Trust Award for Best Managed Security Service for Four Years Running 2Health News:Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM) 2Health News:Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM) 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: